HomeMy WebLinkAbout2009-059 Health - Robert E. Dupuis Contract for Pharmacy Services for the Orange County Health Department~ ~ G "~' ° j
~a
Pharmacy Contract
July 1, 2009 -June 30, 2010
CONTRACT FOR PHARMACY SERVICES FOR THE ORANGE
COUNTY HEALTH DEPARTMENT
This contract is between Robert E. Dupuis, herein referred to as "Contractor," and the Orange
County Health Department, hereinafter referred to as the "Department." It shall be effective July
1, 2009 and shall terminate on June 30, 2010. It is understood that the Contractor will provide
direct pharmacy services at the two pharmacy sites of the Health Department. It is further
understood that there will be mutual cooperation between the Contractor and the Department in
conducting the activities as described below:
The Contractor agrees to:
A. Adm inistrative Duties
1. Assist in the development of written policies and procedures for legal,
safe and effective drug therapy, distribution, control and use.
2. Work with the Department pharmacy nurse in:
a. Developing and maintaining a formulary
b. Evaluating and improving procedures for drug procurement,
storage, packaging and labeling
3. Work with the Department Assurance Nurse in the Medication Assistance
Program (MAP) in:
a. Verifying correct drug and dosage sent by drug companies
b. Splitting drugs as requested by clinician
c. Labeling drugs
d. Notifying Assurance Nurse when drugs are ready for dispensing
4. Oversee all activities related to the operation of the pharmacies at the
Hillsborough Whitted Center and Chapel Hill Southern Human Services
Center.
5. Prepare and submit a quarterly report reviewing pharmacy activities and
related issues.
6. Prepare and submit an annual report summarizing pharmacy activities
and accomplishments for the current year and goals/plans for the next
year.
7. Assist the Clinical Services Nursing Supervisor in budget preparation for
pharmaceuticals and related supplies, when requested.
8. Assist the Clinical Services Nursing Supervisor in acquiring
pharmaceuticals in acost-efficient manner.
9. Evaluate and improve therapeutics within the Health Department.
10. Provide pharmacy training for new public health nurses and nurse
practitioners.
11. Evaluate pharmaceutical software for Health Department pharmacy
functions as requested by the Division Director.
12. To the extent the Contractor keeps records, the Contractor agrees to
make all such records available to the Department for auditing, reporting
or any other purpose deemed necessary by the Department.
B. Drug Distribution
1. Prepack stock formulary pharmaceuticals adhering to pharmacy law
requirements and ensuring maintenance of adequate prepacked
supplies.
2. Label medications received through the Medication Assistance Program
(MAP).
3. Review dispensing logs at all Health Department sites weekly.
4. Review dispensing Ibgs within 24 hours when more than 30 prescriptions
have been distributed.
Page 1 of 3
S:\Managers Working Files\Contracts\PHARMACY\FY 20101pharmacy contract 09-10.doc
Pharmacy Contract
July 1, 2009 -June 30, 2010
5. Maintain the drug distribution system in compliance with_all laws,
regulations and standards.
6. Provide drug information on an on-call basis when needed by staff.
7. Assist with the development and/or the procurement of necessary drug
information/patient education materials to include information in
languages other than English when needed.
8. Be available to directly dispense medications not approved for public
health nurse dispensing in times of communicable disease outbreaks.
9. Review at least 3 clinical charts from each site monthly, comparing them
to the dispensing log for accuracy and completeness. Document
findings in the "OCHD Pharmacy Quality Assurance Indicator, Chart
Review" log.
10. Complete pharmacy incident report on all errors and forward to the
Clinical Nursing Supervisor for development of corrective actions.
11. Comply with such non-discrimination laws and/or employment practices
as may be applicable in fulfilling this contract.
II. The Department agrees to:
A. Designate a nursing supervisor to provide guidance and assistance with related
administrative or technical aspects of providing pharmacy services at Health
Department sites as requested.
B. Participate in the ongoing evaluation of the role of the pharmacist and provide an
annual evaluation of pharmacist's performance of contract.
C. Pay the Contractor in return for the contracted deliverable services a total of
$12, 036 per year payable in 12 equal installments of $1003 each upon invoice
from the Contractor.
D. Enable the pharmacist to perform all activities mandated by laws, regulations and
standards.
E. Obtain required pharmacy licenses for all sites.
F. Allow the pharmacist to participate in other related activities in the Health
Department as agreed to by both parties
G. Comply with such non-discrimination laws and/or employment practices as may
be applicable in fulfilling this contract.
III. Confidentiality
The Contractor agrees to sign the OCHD Personal Health Services Division
Confidentiality Agreement and agrees to maintain confidentiality per this Agreement. The
Contractor will comply with such confidentiality laws as may be applicable in the
performance of this agreement and acknowledges that in receiving, storing, processing or
otherwise dealing with any confidential information, Contractor will safeguard and not
further disclose the information except as permitted by the Health Insurance Portability
and Accountability Act of 1996, Public Law 104-191, as amended.
IV. Licensure
The Contractor agrees to maintain current North Carolina Pharmacy Licensure and to
present proof of licensure annually.
V. Insurance/Liability
A. The Contractor agrees to obtain personal liability insurance and agrees that they
are operating as an Independent Contractor and that no benefits, including
Worker's Compensation coverage, is available to them from Orange County.
Proof of insurance will be presented to the Department annually.
B. The Contractor agrees to hold Orange County and the Department harmless
from any and all accidental injury or personal loss during pharmacy services to
the Department.
Page 2 of 3
S:\Managers Working Files\ContractslPHARMACY\FY 2010\pharmacy contract 09-10.doc
Pharmacy Contract
July 1, 2009 -June 30, 2010
VI. Termination
Either party may terminate this agreement without cause with 60 days written notice.
This agreement may be terminated with cause at any time by either party upon at least
30 days prior written notice to the other party upon default of one or more of its
obligations hereunder, unless such default is cured within 30 days of the notice of
termination.
IN WITNESS WHEREOF, the Contractor and the Department have executed this
agreement in duplicate originals, one of which is retained by each of the parties.
CONTR TOR:
~ ~ o~ ~
obert E. Dupuis, Pharm. ., BCPS Dat
FOR AND ON BEHALF OF THE ORANGE COUNTY HEALTH DEPARTMENT:
Rosemary L ummers, Health Director Da e
Orange Cou y Health Department
FORA BEH F OF THE COUNTY OF ORANGE:
~.e~.=. ~ zS ~
Valerie Foushee, C air Da e
Orange County Board of Commissioners
ORANGE COUNTY FINANCE DIRECTOR
"This instrument has been pre-audited in the
manner required by the Local Government
Budget and Fiscal Control Act."
__
frG
u rey Da
Orange County finance Director
Page 3 of 3
S:\Managers Working Files\Contracts\PHARMACY\FY 2010\pharmacy contract 09-10.doc
BUSINESS ASSOCIATE AGREEMENT
This Agreement is made effective the 1St Day of July 2009, by and between Orange
County Government, Health Department, hereinafter referred to as "Covered Entity", and
Robert Dupuis, Pharm D, BCPS, hereinafter referred to as "Business Associate," (individually, a
"Party" and collectively, the "Parties").
WITNESSETH:
WHEREAS, Sections 261 through 264 of the federal Health Insurance Portability and
Accountability Act of 1996, Public Law 104-191, known as "the Administrative Simplification
provisions," direct the Department of Health and Human Services to develop standards to
protect the security, confidentiality and integrity of health information; and
WHEREAS, pursuant to the Administrative Simplification provisions, the Secretary of Health
and Human Services has issued regulations modifying 45 CFR Parts 160 and 164 (the "HIPAA
Privacy Rule"); and
WHEREAS, the Parties wish to enter into or have entered into an arrangement whereby
Business Associate will provide certain services to Covered Entity, and, pursuant to such
arrangement, Business Associate may be considered a "business associate" of Covered Entity as
defined in the HIPAA Privacy Rule (the agreement evidencing such arrangement is entitled
"Contract for Pharmacy Services for the Orange County Health Department" dated July 1, 2009-
June 30, 2010, and is hereby referred to as the "Arrangement Agreement"); and
WHEREAS, Business Associate may have access to Protected Health Information (as
defined below) in fulfilling its responsibilities under such arrangement;
THEREFORE; in consideration of the Parties' continuing obligations under the
Arrangement Agreement, the Parties agree to the provisions of this Agreement in order to
address the requirements of the HIPAA Privacy Rule and to protect the interests of both Parties.
DEFINITIONS
Except as otherwise defined herein, terms used in this Agreement shall have the same meaning
as those terms set forth in the HIPAA Privacy Rule.
II. CONFIDENTIALITY REQUIREMENTS
(a) Business Associate shall:
(i) use or disclose any protected health information solely as
permitted or required by this Agreement, the Arrangement Agreement (if
consistent with this Agreement and the HIPAA Privacy Rule), or as required by law.
(ii) ensure that its agents, if any, including a subcontractor, to whom it
provides protected health information received from or created by Business
Associate on behalf of Covered Entity, agrees to the same restrictions and
conditions that apply to Business Associate with respect to such information. In
addition, Business Associate agrees to take reasonable steps to ensure that its
employees' actions or omissions do not cause Business Associate to breach the
terms of this Agreement;
Page 1 of 4
S:\Managers Working Files\Contracis\PHARMACY\FY 2010\09-10 OCBAA with Dupuis.doc
(iii) implement appropriate safeguards to prevent use or disclosure of
protected health information other than as permitted or required by this
Agreement;
(iv) permit the Secretary of Health and Human Services to audit
Business Associate's records and practices related to use and disclosure of
protected health information to ensure Covered Entity's compliance with the
terms of the HIPAA Privacy Rule;
(v) report to Covered Entity any use or disclosure of protected health
information which is not in compliance with the terms of this Agreement of which
it becomes aware; and
(vi) mitigate, to the extent practicable, any harmful effect that is
known to Business Associate of a use or disclosure of protected health information
by Business Associate in violation of the requirements of this Agreement.
(b) Notwithstanding the prohibitions set forth in this Agreement or the Arrangement
Agreement, Business Associate may use and disclose protected health
information as follows:
(i) if necessary, for the proper management and administration of
Business Associate or to carry out the legal responsibilities of Business Associate,
provided that as to any such disclosure, the following requirements are met:
(A) the disclosure is required by law; or
(B) Business Associate obtains reasonable assurances from the
person to whom the information is disclosed that it will be held
confidentially and used or further disclosed only as required by law or for
the purpose for which it was disclosed to the person, and the person
notifies Business Associate of any instances of which it is aware in which
the confidentiality of the information has been breached;
(ii) for data aggregation services, if such services are to be provided
by Business Associate for the health care operations of Covered Entity pursuant to
any agreements between the Parties evidencing their business relationship.
III. AVAILABILITY OF PROTECTED HEALTH INFORMATION
Business Associate shall:
(a) at the request of Covered Entity, provide access to protected health information
in a designated record set to Covered Entity or, as directed by Covered Entity, to
an individual, in a time and manner sufficient to permit Covered Entity to comply
with the requirements of 45 CFR 164.524.
(b) at the request of Covered Entity or an individual, make any amendment(s) to
protected health information in a designated record set that are directed by or
agreed to by Covered Entity, in a time and manner sufficient to permit Covered
Entity to comply with the requirements of 45 CFR 164.526.
(c) document disclosures of protected health information and information related to
such disclosures in a manner sufficient to permit Covered Entity to respond to a
request by an individual for an accounting of disclosures of protected health
information in accordance with 45 CFR 164.528 and provide such documentation
to Covered Entity or an individual as directed by Covered Entity.
Page 2 of 4
S:\Managers Working Files\Contracts\PHARMACY\FY 2010\09-10 OCBAA with Dupuis.doc
IV. TERMINATION
(a) Term: This Agreement terminates when the Arrangement Agreement terminates
or as provided in Paragraph IV.b. below (termination for cause).
(b) Termination for cause: Upon Covered Entity's knowledge of a material breach by
Business Associate, Covered Entity shall either:
(i) provide an opportunity for Business Associate to cure the breach
or end the violation or, if Business Associate does not cure the breach or end the
violation within the time specified by Covered Entity, terminate this Agreement
and the Arrangement Agreement; or
(ii) immediately terminate this Agreement and the Arrangement
Agreement if Business Associate has breached a material term of this Agreement
and cure is not possible.
(c) Return or destruction of protected health information: At termination of this
Agreement, the Arrangement Agreement (or any similar documentation of the
business relationship of the Parties), or upon request of Covered Entity, whichever
occurs first, Business Associate shall:
(i) if feasible, return or destroy all protected health information
received from or created or received by Business Associate on behalf of Covered
Entity that Business Associate still maintains in any form. Business Associate shall
only destroy protected health information with the written approval of Covered
Entity. After return or destruction, Business Associate shall retain no copies of such
information.
(ii) if return or destruction is not feasible, Business Associate will provide
Covered Entity with documentation explaining the reason that it is not feasible. If
the protected health information is not returned or destroyed, Business Associate
will extend the protections of this Agreement to the information and limit further
uses and disclosures to those purposes that make the return or destruction of the
information not feasible.
(d) Survival: The obligations of Business Associate under this Agreement shall survive
the expiration, termination, or cancellation of this Agreement, the Arrangement
Agreement and/or the business relationship of the .parties, and shall continue to
bind Business Associate, its agents, employees, contractors, successors, and
assigns as set forth herein.
V. MISCELLANEOUS
(a) All protected health information that is created or received by Covered Entity
and disclosed or made available in any form, including paper record, oral
communication, audio recording, and electronic display by Covered Entity or its
operating units to Business Associate or is created or received by Business
Associate on Covered Entity's behalf shall be subject to this Agreement.
(b) A reference in this Agreement to a section in the HIPAA Privacy Rule means the
section as in effect or as amended.
(c) In the event of an inconsistency between the provisions of this Agreement
(including definitions) and mandatory provisions of the HIPAA Privacy Rule, as
Page 3 of 4
S:\Managers Working Files\Contracts\PHARMACY\FY 2010\09-10 OCBAA with Dupuis.doc
amended, the HIPAA Privacy Rule shall control. Where provisions of this
Agreement are different than those mandated in the HIPAA Privacy Rule, but are
nonetheless permitted by the HIPAA Privacy Rule, the provisions of this Agreement
shall control.
(d) Except as expressly stated herein or the HIPAA Privacy Rule, the parties to this
Agreement do not intend to create any rights in any third parties.
(e) This Agreement may be amended or modified only in a writing signed by the
Parties. No Party may assign its respective rights and obligations under this
Agreement without the prior written consent of the other Party. None of the
provisions of this Agreement are intended to create, nor will they be deemed to
create any relationship between the Parties other than that of independent
parties contracting with each other solely for the purposes of effecting the
provisions of this Agreement and any other agreements between the Parties
evidencing their business relationship.
(f) This Agreement will be governed by the laws of the State of North Carolina.
(g) No change, waiver or discharge of any liability or obligation hereunder on any
one or more occasions shall be deemed a waiver of performance of any
continuing or other obligation, or shall prohibit enforcement of any obligation, on
any other occasion.
(h) The parties agree that, in the event that any documentation of the arrangement
pursuant to which Business Associate provides services to Covered Entity contains
provisions relating to the use or disclosure of protected health information that
are more restrictive than the provisions of this Agreement, the provisions of the
more restrictive documentation will control
(i) In the event that any provision of this Agreement is held by a court of competent
jurisdiction to be invalid or unenforceable, the remainder of the provisions of this
Agreement will remain in full force and effect.
(j) The headings in this Agreement are for convenience of reference only and shall
not define or limit any of the terms or provisions hereof.
IN WITNESS WHEREOF, the Parties have executed this Agreement as of the day and year
written above.
COVERED ENTITY:
s ~-
,. ~
BUSINESS ASSOCIATE:
By: `~/ 2~-..
~f ~ ~ -
1 + , 'c- .-'`~ (. lL . ,., /Nil G j _f
Title: - )~"~ ~ t. ~ Title: /rte /~/! .~
vi
Page 4 of 4
S:\Managers Working Files\Contracts\PHARMACY\FY 2010\09-10 OCBAA with Dupuis.doc